Open Access

An enzyme-linked immunosorbent assay for detection of avian influenza virus subtypes H5 and H7 antibodies

  • Trine H Jensen1, 5Email author,
  • Gitte Ajjouri1,
  • Kurt J Handberg1,
  • Marek J Slomka2,
  • Vivien J Coward2,
  • Martine Cherbonnel3,
  • Véronique Jestin3,
  • Peter Lind4 and
  • Poul H Jørgensen1
Acta Veterinaria Scandinavica201355:84

https://doi.org/10.1186/1751-0147-55-84

Received: 7 July 2013

Accepted: 18 November 2013

Published: 21 November 2013

Abstract

Background

Avian influenza virus (AIV) subtypes H5 and H7 attracts particular attention because of the risk of their potential pathogenicity in poultry. The haemagglutination inhibition (HI) test is widely used as subtype specific test for serological diagnostics despite the laborious nature of this method. However, enzyme-linked immunosorbent assays (ELISAs) are being explored as an alternative test method.

H5 and H7 specific monoclonal antibodies were experimentally raised and used in the development of inhibition ELISAs for detection of serological response specifically directed against AIV subtypes H5 and H7. The ELISAs were evaluated with polyclonal chicken anti-AIV antibodies against AIV subtypes: H1N2, H5N2, H5N7, H7N1, H7N7, H9N9, H10N4 and H16N3.

Results

Both the H5 and H7 ELISA proved to have a high sensitivity and specificity and the ELISAs detected H5 and H7 antibodies earlier during experimental infection than the HI test did. The reproducibility of the ELISA’s performed at different times was high with Pearson correlation coefficients of 0.96-0.98.

Conclusions

The ELISAs are a potential alternative to the HI test for screening of large amounts of avian sera, although only experimental sera were tested in this study.

Keywords

Avian influenzaMonoclonal antibodyInhibition ELISAH5H7SerologyHaemagglutination inhibition testExperimental sera

Background

Avian influenza is an emerging global challenge regarding the potential for pandemics with severe impact on the avian health and economy, reviewed by [1]. Of special concern is the avian influenza virus (AIV) subtype H5 and H7, which have potentials to become highly pathogenic avian influenza (HPAI) [2]. The zoonotic potential of H5 and H7 infections [3, 4] and the severe impact of HPAI infections for the poultry industry [5] emphasise the need for sensitive and effective diagnostic methods and surveillances to early detect low pathogenic avian influenza infections. For this purpose, many national serological surveillance programmes rely on the use of haemagglutination inhibition (HI) test [6]. However, for screening of high numbers of samples the enzyme-linked immunosorbent assay (ELISA) techniques are superior in throughput, speed and less independent of many different antigen cultures which are needed for the HI test. Several ELISAs for detection of antibodies against the AIV nucleoprotein (NP) using inactivated NP antigen [7, 8], recombinant proteins [913] and antigens expressed in yeast [14] have been described. These ELISAs have been tested with field sera and sera from experimentally inoculated birds of a number of different avian species including chicken [79, 1113, 15], turkey [9, 13], emu [9, 13], ostrich [8, 9, 13] and duck [7, 8, 10]. Additionally, commercially available kits for AIV antibody detection have been compared to the HI test and agar gel immodiffusion (AGID) test [1620]. These kits had higher sensitivity compared to the AGID when testing duck and wild bird sera [16, 19, 21]. One kit had higher sensitivity compared to HI test of a number of poultry species including duck [17], while another kit had no higher sensitivity testing domestic duck sera in comparison with the HI test [19].

ELISAs targeting H7 antibodies by use of inactivated H7 antigen [22], partially purified H7N1 antigen [23] or purified recombinant H7 protein [24] have been published. The use of recombinant protein for coating the ELISA plates may avoid steric interference by the neuraminidase protein (N) [24, 25]. Inactivated whole antigen is practically applicable although it can cause problems most likely related to interference with the N protein [24]. ELISA employing a H5 monoclonal antibody (mAb) and purified H5N2 virus as coating antigen has so far been described for detection of H5 antibodies in chickens during an outbreak of A/chicken/Taiwan/1209/03(H5N2) [26] and for wild aquatic birds in Italy [27]. Two promising studies of H5 ELISA also using H5 mAb was recently described for testing of chickens, turkeys and ducks [25, 28].

The continuing circulation and threat of subtypes H5 and H7 AIV (reviewed in [29]) sustain an increasing demand for diagnostic tools to detect antibodies specifically against these AIV subtypes. Consequently, we developed H5 and H7 mAbs for use in ELISA and immunocytochemistry. These H5 and H7 mAbs were applied in inhibition ELISAs and evaluated with antibodies raised experimentally in SPF chickens against a number of different AIV subtypes: H1N2, H5N2, H5N7, H7N1, H7N7, H9N9, H10N4, H16N3. The mAbs recognised AIV subtypes H5 and H7 respectively, of diverse geographic regions. Furthermore, we address the question of steric hindrance of the N component by suggesting doing a secondary ELISA test with another N type as coating antigen. The ELISA proved to be more sensitive than the HI test.

Materials and methods

Identity and preparation of antigen for development of the ELISA

Several influenza A strains were used for production of chicken sera for development of the ELISA test and for HI test (Table 1): A/ostrich/Denmark/72429/96 (H5N2); A/chicken/Belgium/150/99 (H5N2); A/mallard/Denmark/64650/03 (H5N7); A/African starling/England/983/79 (H7N1); A/turkey/Ireland/95 (H7N7); A/mallard/Denmark/64650G4/05 (H7N7); A/knot/England/SV497/02 (H9N9); A/turkey/England/284/79 (H10N4); A/gull/Denmark/48110/02 (H16N3) and A/swine/Denmark/13608/04 (H1N2). Avian paramyxovirus (APMV)-8/goose/Delaware/1053/76 was used to obtain AIV negative control serum. Except for the Danish avian influenza isolates [30, 31] the strains were kindly supplied by the EU Reference Laboratory for Avian Influenza AHVLA, Weybridge, UK (EURL).
Table 1

Avian influenza strains used for raising antibodies in chickens

Antigen

Origin

Animal

Number of animals

Age immunisation (weeks)

Blood samples weeks after 1. imm.

H5N2

VET

SPF

15

3

1, 2, 3, 4, 6

A/ostrich/Denmark/72429/96

     

H5N2

VET

Broiler

15

3

1, 2, 2½, 3, 6

A/ostrich/Denmark/72429/96

     

H5N2

EURL

SPF

15

3, 5, 7

1, 2, 3, 4, 6

A/chicken/Belgium/150/99

     

H5N7

VET

SPF

15

3, 5, 7

1, 2, 3, 4, 6

A/mallard/Denmark/64650/03

     

H7N1

EURL

SPF

17

3, 5, 7

1, 2, 3, 4, 6

A/African starling/England/983/79

     

H7N1

EURL

Broiler

10

3, 5, 7

1, 2, 3, 4, 6

A/African starling/England/983/79

     

H7N7

EURL*

SPF

15

3, 5, 7

1, 2, 3, 4, 6

A/turkey/Ireland/95

     

H9N9

EURL*

SPF

14

3, 5, 7

1, 2, 3, 4, 6

A/knot/England/02

     

H10N4

EURL

SPF

16

3, 5, 7

1, 2, 3, 6

A/turkey/England/384/79

     

H16N3

VET

SPF

12

4, 6, 8

1, 2, 3, 4, 5

A/gull/Denmark/7468110/02

     

PMV

VET

SPF

13

3, 5, 7

1, 3, 5

APMV-8/goose/Delaware/1053/76

     

H1N2

VET

SPF

15

3, 5, 7

1, 2, 3, 4, 6

A/swine/Denmark/13608/04

     

*received inactivated and used directly.

imm. - immunisation.

VET- National Veterinary Institute, Technical University of Denmark.

EURL- EU Reference Laboratory for Avian Influenza, Virology Department, AHVLA Weybridge, UK.

SPF- Specific pathogen free.

Broiler- commercial broiler chickens.

The virus was propagated by inoculation in the allantoic cavity of 8-10 days old specific pathogen free (SPF) embryos (Lohmann Tierzucht, Cuxhaven, Germany). Eggs were candled daily and allantoic fluid was harvested from dead embryos. The virus was inactivated by addition of 1:1,200-2,000 β-propiolactone (Acros Organics, Geel, Belgium) to the harvest. Inactivation was confirmed by 3 blind passages in SPF eggs.

Production and characterisation of H5 and H7 mAb

The mAb specific for the H5 (Hyb 355-02) was produced by immunisation of female Balb/c mice with sucrose purified H5N2 influenza virus A/chicken/Belgium/150/99 (H5N2). All animal experiments were conducted according to and approved by the Danish Animal Care and Ethics Committee.

The mAb specific for the H7 (Hyb 351-01) was produced by immunisation of female Balb/c mice with DNA plasmid (pCMV-HA) [32] (kindly provided by Anses, Ploufragan-Plouzané Laboratory, France). The H5 mAb was of IgG1 subtype and the H7 mAb was of IgG subtype while characterised using Mouse MonoAB ID kit (Zymed, California, USA) according to the manufactures protocol.

The specificity of the H5 and H7 mAbs was evaluated by direct ELISA and immunocytochemistry using 44 AIV strains belonging to 24 AIV subtypes (Table 2). The direct ELISAs to test for cross-reactivity of the H5 and H7 mAb were performed with ELISA plates coated with the different AIV antigens diluted according to their HA titer: A/duck/Alberta/35/76 (H1N1), A/chicken/Scotland/59 (H5N1), A/chicken/Belgium/150/99/ (H5N2), A/turkey/Ireland/83 PD1744/83 (H5N8), A/turkey/Ontario/7732/66 (H5N9), A/chicken/Netherlands/2992/17/03 (H7N7), A/turkey/England/384/79 (H10N4). Subsequently, the plates were incubated with mAbs diluted and subsequently processed as described for the inhibition ELISA in this article. The immunocytochemistry was done on chicken embryo fibroblast (CEF) infected with the different AIV strains (Table 2). The CEFs were fixed in 3% formaldehyde in phosphate buffered saline (PBS) and the immunocytochemistry was done as described previously [33]. 3-Amino-9-Ethylcarbazole (AEC, DAKO Cytomation, Denmark) were used to visualise the reaction between infected cells and mAbs according to standard procedures (DAKO Cytomation).
Table 2

Pattern of reactivity of H5 and H7 mAb against avian influenza viruses

Avian influenza isolates used for IPX and ELISA*

Monoclonal antibodies

 

H5

H7

H7N1 A /duck/Taiwan/98 LP

nd

+

H7N1 A/chicken/Italy/99 LP

nd

+

H7N1 A/ostrich/South_Africa/91 LP

nd

+

H7N1 A/duck/Denmark/08 LP

-

+

H7N2 A/chicken/Wales/07 LP

-

+

H7N3 A/chicken/Pakistan/95 HP

nd

+

H7N3 A/chicken/Chile/02 HP

-

+

H7N3 A/chicken/British _Columbia/514/04 HP

-

+

H7N3 A/chicken/England/06 LP

-

+

H7N3 A/chicken/Saskatchewan/07 HP

-

+

H7N7 A/chicken/Netherlands/03 HP

nd

+

H7N7 A/turkey/Ireland/98 LP

nd

+

H7N7 A/turkey/England/08 HP

-

+

H5N1 A/turkey/Turkey/05 HP

nd

-

H5N2 A/chicken/France/03 LP

nd

-

H5N2 A/mallard/Denmark/06 LP

+

-

H5N2 A/mallard/Denmark/60347/06 LP

nd

-

H5N2 A/turkey/Italy/05 LP

+

-

H5N3 A/domestic duck/Italy/04 LP

nd

-

H5N9 A/chicken/Italy/97 LP

+

-

H1N1 A/turkey/Hungary/01

nd

-

H2N3 A/mallard/England/06

nd

-

H3N2 A/duck/Singapore/02

nd

-

H4N6 A/duck/Denmark/02

nd

-

H6N1 A/teal/7394/England/06

nd

-

H6N2 A/teal/7440/England/06

nd

-

H8N4 A/turkey/Ontario/68

nd

-

H9N2 A/mallard/England/06

nd

-

H9N2 A/chicken/Iran/99

nd

-

H10N7 A/mallard/England/06

nd

-

H10N7 A/chicken/England/01

nd

-

H11N3 A/duck/Singapore/02

nd

-

H13N6 A/herring gull/Finland/05

nd

-

H14N6 A/mallard/Gurjev/91

nd

-

H16N3 A/gull/Sweden/03

nd

-

H1N1 A/duck/Alberta/35/76*

-

nd

H5N1 A/chicken/Scotland/59*

+

nd

H5N2 A/chicken/Belgium/150/99*

+

nd

H5N7 A/mallard/Denmark/75-64650/03*

+

nd

H5N8 A/turkey/Ireland/83*

+

nd

H5N9 A/turkey/Ontario/66*

+

nd

H7N1 A/African starling/England/983/79*

-

+

H7N7 A/chicken/Netherlands/2992/17/03*

-

+

H10N4 A/turkey/England/384/79*

-

nd

IPX immunochemistry with immunoperoxidase test.

Uninfected CEFs were used as controls.

*tested by ELISA.

nd- not done.

Sera

Experimentally produced polyclonal sera against H1, H5, H7, H9, H10 and H16 were obtained by immunisation of SPF chickens (Lohmann Tierzucht) with influenza A strains as listed in Table 1. In addition to the SPF chickens, commercial broilers were immunised with A/ostrich/Denmark/72429/96 (H5N2) and A/African starling/England/983/79 (H7N1), respectively.

The birds (Table 1) were immunised at the age of 3, 5 and 7 weeks intramuscularly with 0.4 ml of β- propiolactone inactivated allantoic fluid (H5 and H7) and incomplete Freunds adjuvant (DIFCO Laboratories, Detroit, Michigan) in equal amounts. The birds immunised with H1, H9, H10 and H16 were given live virus orally and into the conjunctiva at the first immunisation and subsequently immunised with inactive allantoic fluid with incomplete Freunds adjuvant at the second and third immunisation.

Negative control sera from 14 SPF chickens were tested by HI test for antibodies against H5 and H7 influenza virus, Newcastle disease virus, Egg drop syndrome virus and Infectious bronchitis virus with negative results. Additionally, sera from 13 SPF chickens immunised with APMV-8/goose/Delaware/1053/76 were used as negative controls.

HI test

The HI test of sera was performed according to the OIE Manual [6] by use of a 2-fold sera dilution and 4 haemagglutination (HA) antigen units. Chicken red blood cells (RBCs 1%, SPF chickens, Lohmann, Germany) were used. The plates were incubated at 4°C for 30 minutes and read after tilting of the plates. The HI titre was determined as the value of the highest dilution of serum causing complete inhibition of the 4 HA units of virus. Titres < 16 were considered negative in accordance with the OIE Manual [6]. All sera were tested by HI test with a homologous inactivated virus. In addition a number of sera of each subtype were tested against H5N2, H5N7, H7N1 and H7N7 inactivated virus (data not shown).

Inhibition ELISA

ELISA plates (MaxiSorp, Nunc, Denmark) were coated with allantoic fluid harvested from SPF eggs inoculated with A/mallard/Denmark/64650/03 (H5N7) diluted 1:250 in PBS according to the HA titer of 1:256. Coated plates were kept up to 14 days at 4°C. Before use, the plates were washed 3 times (Skan Washer 300 version B, Molecular Devices) with washing buffer (PBS with 0.05% Tween 20). The test sera were diluted 1:10 in PBS containing 1% bovine serum albumin (BSA) (A9647-100G, Sigma, Denmark). A panel of positive and negative control sera was included in parallel on each plate and all sera were tested in duplicate, 100 μl of diluted serum were added to each of 2 wells and incubated for 1 hour at room temperature (rt). Subsequently, the serum dilutions were discharged by turning the plates up-side down and 100 μl of the monoclonal antibody H5 mAb Hyb 355-02 (0.025 μg/ml in PBS + 1% BSA) were added to each well. After incubation for 1 hour at rt the plates were washed as described above and 100 μl horse-radish-peroxidase conjugated polyclonal rabbit anti-mouse IgG (P0260, DakoCytomation, Glostrup, Denmark) diluted 1:1,000 in PBS + 1% BSA were added to each well. After incubation for 1 hour at rt, the plates were washed as described above and 100 μl of 1.2-phenylen-diamine-dihydrochlorid (OPD, Kem-En-Tech Diagnostics A/S, Denmark) were applied to each well. The colour development was stopped by adding 100 μl of H2SO4 0.5 M. The optical density (OD) value of each test well was read at 492 nm with a reference of 620 nm. The percentage of inhibition (Inh%) was calculated including the mean of the OD values of the sera tested in duplicate (OD sample) and the mean of the maximum OD values for the negative control wells only containing PBS (ODmax):
Inhibition % , Inh % = ODmax - ODsample ODmax × 100

Similarly, ELISA plates were coated with inactivated A/African starling/England/983/79 (H7N1) diluted 1:300 in PBS and the procedure were as described above except for the use of the monoclonal antibody H7 mAB Hyb351-01 (0.025 μg/ml in PBS + 1% BSA).

Subsequently, a number of sera of different AIV subtypes were tested with H5N2 and H7N7 antigen to eliminate steric hindrance of the N component (Tables 3 and 4). Thus a system with 2 subsequent ELISAs was developed. First one ELISA with a specific antigen e.g. H5N7 for screening was performed followed by a second ELISA using another antigen e.g. H5N2 to exclude influence from steric hindrance of the N component. So for each serum, the final result was expressed as the lowest inhibition percentage given by ELISA.
Table 3

Results of testing of the heterologous sera in the H5 inhibition ELISAs

Immunisation

PMV8 (n = 8)

H16N3 (n = 10)

H1N2 (n = 7)

H9N9 (n = 7)

H10N4 (n = 16)

H7N1 (n = 20)

H7N7 (n = 12)

H5N7ag-ELISA

6.3 (13.5)

21.5 (31.0)

19.7 (26.7)

19.1 (27.9)

13.3 (18.3)

17.6 (26.6)

42.3 (55.8)

 

16.2 (28.0)

 

H5N2ag-ELISA

8.4 (11.9)

11.3 (15.1)

12.9 (18.7)

7.4 (11.7)

2.8 (12.2)

3.6 (18.6)

3.0 (17.8)

 

6.0 (18.7)

 

2 subsequent ELISA

5.6 (12.5)

11.3 (15.1)

12.9 (18.7)

7.4 (11.7)

2.7 (11.3)

3.6 (18.6)

3.0 (17.8)

 

5.7 (18.3)

 

Values are given as mean inhibition percentages and mean + 2 standard deviations (in brackets). Two subsequent ELISA implies that the first ELISA is done using the H5N7 antigen and then a secondary ELISA is performed with the H5N2 antigen. The minimum value for the two assays is used as the final result.

Table 4

Results of testing of the heterologous sera in the H7 inhibition ELISAs

Immunisation

PMV8 (n = 7)

H16N3 (n = 6)

H1N2 (n = 11)

H9N9 (n = 7)

H10N4 (n = 13)

H5N7 (n = 14)

H5N2c (n = 11)

H5N2o (n = 20)

H7N1ag-ELISA

-6.6 (10.1)

10.3 (17.3)

12.8 (22.1)

12.0 (19.6)

19.6 (38.2)

12.1 (25.7)

5.2 (11.0)

13.5 (26.1)

 

11.3 (29.3)

H7N7ag-ELISA

0.6 (6.1)

6.8 (22.2)

3.3 (17.3)

13.0 (25.7)

1.1 (13.2)

15.7 (30.2)

3.1 (12.0)

1.7 (14.6)

 

4.4 (19.9)

2 subsequent ELISA

-7.1 (7.6)

4.3 (14.7)

3.1 (16.2)

10.1 (18.1)

1.1 (13.2)

11.1 (24.0)

2.7 (10.7)

1.7 (14.4)

 

3.0 (17.7)

Values are given as mean inhibition percentages and mean + 2 standard deviations (in brackets). 2 subsequent ELISA implies that the first ELISA is done using the H5N7 antigen and then a secondary ELISA is performed with the H5N2 antigen.

All sera were tested twice in duplicate to test for reproducibility. The second test was always performed with a different batch of antigen coated ELISA plates and at least 1 month since the first test and in most cases also by different technicians.

Statistical analysis

Calculations of mean values, standard deviations and coefficients of linear regression were done as standard descriptive procedures. For the 2-curve receiver operating characteristic (ROC) true positive sera were defined as those originating from the first blood sampling with a homologous HI-titer ≥ 16 (either H5- or H7-specific depending on the H5- or H7-based ELISA assessed respectively). True negative sera were selected as the latest blood sample of a heterologous infection provided a HI-titer ≥ 16 was evident with the respective homologous H-protein. For example serum from a chicken infected with H5N2 developed a HI titer ≥ 16 tested with H5N2 antigen was used as negative serum in the calculations for the H7 ELISA.

Results

Specificity of the H5 and H7 mAbs

The H5 and H7 mAbs were specific as they recognised only H5 and H7 subtype AIV strains shown by immunocytochemistry and direct ELISA coated with various AIV strains (Table 2).

Specificity and sensitivity of the H5 inhibition ELISA

For studies of specificity heterologous sera from chickens immunised with PMV8, H16N3, H1N2, H9N9, H10N4 and H7N1 were chosen. For each chicken the final blood sample (5 or 6 weeks after immunisation, Table 1) was selected, provided this sera was positive in the HI-test (titer ≥16). When H5N7 inactivated virus were used as coating antigen the majority of these heterologous sera resulted in Inh% below 30. When H7N7 antisera were tested in the ELISA the results varied from 28 to 52 Inh%. With H5N2 virus as coating antigen low responses (below 20 Inh%) were obtained for the same sera, H1N2 sera yielding the highest mean response (12.9 Inh%) (Table 3). Means and standard deviations for the two assays and for 2 subsequent ELISAs, where the minimum value for the two assays are used as the final result are shown in Table 3. The Mean + 2 standard deviations for the 2 subsequent ELISA was 18.3 Inh%.

The first seropositive blood sample (based on HI test) from each animal were used for identification of the optimal cut-off value. ROC-curves for variable cut-off’s were produced. Using a total of 127 sera (50 true positive and 77 true negative) the 2 subsequent ELISA produced an almost perfect ROC-curve, with 98% sensitivity and 100% specificity using a cut-off at 20 Inh% (Figure 1A).
Figure 1

ROC curves for inhibition ELISAs. A) H5 ELISA and B) H7 ELISA. The lowest of the inhibition% (inh-%) given by each successive ELISA using H5N7ag/H5N2ag for H5, H7N1ag/H7N7ag for H7, is taken into account, Sens: sensitivity, spec: specificity, their percentage is shown in y-axis.

The sensitivity of the H5-ELISA was evaluated by comparison with the results of the HI-test. Sera from chickens immunised with H5N7 virus were tested using H5N2 inactivated virus as coating antigen in the ELISA and as antigen in the HI test. The H5N2 sera were also tested by both tests using inactivated H5N7 virus. Sixty sera taken at the time of immunisation (week 0) from the H5N7- and H5N2-immunised chickens were all below 20 Inh%. At weeks 1, 2 and 3 post immunisation (p.i.) sera was collected from 41 chickens. Antibodies against H5 in the serum samples were detected approximately 1 week earlier with ELISA as compared to HI test (Table 5).
Table 5

Comparison of detection of seroconversion of H5 and H7 antibodies with ELISA and HI test

H5/H7

Number of animals

ELISA

HI

Week 0

60/42

0/3.1

0/0

Week 1

41/27

54/59

2.4/11

Week 2

41/27

88/78

39/63

Week 3

41/27

98/100

93/100

The percentage of chickens which seroconverted in H5-ELISA (cut-off = 20 Inh%) and HI test (cut-off = 16), when sera were tested against heterologous N-antigen (H5N7 sera tested by ELISA plates coated with inactivated H5N2 virus and H5N2 sera tested by inactivated H5N7 antigen). After the slash are shown the percentage of chickens which seroconverted in H7-ELISA (cut-off = 20 Inh%) and HI test (cut-off = 16). Sera were tested in ELISA against heterologous N-antigen (H7N1 sera tested by ELISA plates coated with inactivated H7N7 virus and H7N7 sera tested by inactivated H7N1 virus), while all sera in HI test were tested against H7N1 inactivated virus.

Sensitivity and specificity of the H7 inhibition ELISA

The H7 ELISA sensitivity compared to HI test was calculated the same way as for H5 (Table 5). Also in this case seroconversion was detected almost 1 week earlier with ELISA than with HI test. For the H7-ELISA, the results of ELISA with the heterologous sera are presented in Table 4. Using H7N1 inactivated virus as coating antigen in the ELISA resulted in the highest Inh% (19.6) in the sera from the H10N4 immunised chickens. In comparison coating with the inactivated H7N7 virus resulted in highest Inh% (15.7) in sera from the group of H5N7 immunised chickens. The Mean + 2 standard deviation of the 2 subsequent ELISA was 17.7 Inh%. Using a total of 121 sera (32 true positive and 89 true negative) the ROC-determination for the 2 subsequent ELISA gave a sensitivity of 97% and a specificity of 100% using a cut-off at 20 Inh% (Figure 1B).

Stability of the inhibition ELISA

The ELISA was very stable with a good correlation between repeated ELISA tests: Pearson correlation coefficients were r = 0.96 and r = 0.98 for the H5 inhibition ELISA for sera sampled at week 1 and week 2 p.i., respectively (Figure 2A). For the H7 inhibition ELISA, the corresponding values were: r = 0.96 and r = 0.97 (Figure 2B). The coefficient of variation (standard deviation/mean) was higher for the sera sampled 1 week p.i. (14.1%) compared to sera sampled 2 weeks p.i. (7.6%). This was also the case for H7 inhibition ELISA, the coefficient of variation was 25.0% 1 week p.i. and 6.6% 2 weeks p.i.
Figure 2

Correlation between repeated ELISA testing on different days. (A) H5N7 antigen and (B) and H7N1 antigen, Inh%: Inhibition%.

Discussion

The H5 and H7 mAbs developed in this study appeared to have a high specificity when tested against a variety of AIV strains in ELISA and by immune peroxidase test (Table 2). For practical reasons it was not possible to test all possible H5 and H7 subtypes but due to the high reactivity of the H5 and H7 mAbs it is assumed that these mAbs bind to conservative epitopes largely shared inside strains of the H5 and H7 subtypes respectively. Multipurpose mAbs have many advantages in diagnostic settings [12]. Since only AIV subtype H5 and H7 are reportable to the World Organization for Animal Health (OIE) and consequently the AIV surveillance normally targets two subtypes with the HI test [6], H5 and H7 mAbs were the focus of the present study.

The analysis for specificity revealed interference in the ELISA test with the N protein of the inactivated virus antigen used for coating of the ELISA plates (Tables 3 and 4). When sera raised against H7N7 virus were tested with H5N7 virus as coating antigen the result was positive (Inh% > 20) while negative (Inh% <20, Table 3) with H5N2 virus as coating antigen. H7N1 and H5N7 virus was chosen as coating antigens because these antigens gave the most optimal OD values when tested against serial dilutions of the mAb. However, the differences in OD values between the tested antigens were marginal (data not shown) and hence the ELISA is applicable for antibodies to different N-types of H5 and H7 subtype AIVs. Besides, they are LPAI viruses and were readily available. Whole inactivated virus was chosen as coating antigens because it makes the ELISA applicable in laboratories with no access to sophisticated equipment and reagents like recombinant antigens. Steric hindrance most likely could be circumvented by the use of purified or recombinant antigens for coating [23, 25]. The problem with steric hindrance is known from the HI test as well [24, 34].

To omit the problem for practical applicability this study suggests 2 subsequent ELISAs first using one antigen as screening followed by a secondary antigen to exclude influence from steric hindrance of the N component (Tables 3 and 4). This is in parallel to the general recommendations for AIV serological surveillance [6]. By doing 2 subsequent ELISAs the specificity are increased and the problem with interference of the N protein are omitted for both the H5 and H7 ELISA. It is suggested, based on the ROC curves (Figure 1) to define results in the first ELISA of < 20 Inh% as negative and based on the Inh% of the heterologous sera (Tables 3 and 4) an upper limit of > e.g. 80 Inh% as positive. To define such a limited window of re-testing would reduce the extra cost of performing 2 subsequent ELISAs considerably.

The H5 ELISA was shown to be able to detect antibodies one week earlier compared to the HI test (Table 5). This indicates a superior sensitivity for the performance of 2 subsequent ELISAs in the early phase of an infection with AIV H5. The same was observed with the H7 ELISA (Table 5). The higher relative sensitivity of the ELISA compared to HI test corresponds with the results of other AIV ELISAs [13, 15, 16, 19, 3538]. Hence, it should be considered to replace the more laborious HI test or at least as initial screening in the surveillance [17, 34].

Detailed analysis of the H5 and H7 mAbs used in two subsequent inhibition ELISAs resulted in a specificity of 100% for both the H5 and H7 ELISAs (Figure 1). The specificities were based on experimentally produced sera raised in chickens to homologous antigen and a variety of heterologous AIV antigens and a paramyxovirus (Tables 3 and 4). This high specificity together with the different AIV antigens used to raise the tested sera indicated that the estimates of specificity are reasonable also for field applications. However, the presence of false positives in field sera compared to experimental infections is difficult to predict, so this ELISA is a promising candidate to be evaluated using field sera from different avian species in comparison with HI test. Interestingly, it was found in another work that the HI test was most accurate in detecting antibodies of naturally compared to experimentally infected poultry [34]. Variable sensitivities and specificities have been detected by others [25] for field sera of turkeys, ducks and chicken by the use of a recombinant H5 mAb. However, others presented high sensitivities and specificities with the H5 mAb and partly purified antigens for a variety of field and experimental avian sera [8]. High sensitivities and specificities were also detected in field samples from chickens by a H5 ELISA developed during an outbreak of LPAI H5 in Taiwan [35]. Similar results were described for a H5 ELISA detecting H5 antibodies of wild ducks in Italy [27]. A H7 ELISA based on recombinant H7 mAB and inactivated antigen was shown to have higher sensitivity and specificity with experimental and field sera for use by multiple avian species compared to HI test [23]. Importantly the present H5 and H7 ELISA showed a very high degree of reproducibility (Figure 2).

Conclusions

The inhibition ELISAs based on the H5 and H7 mAb developed in this study and a combination of two inactivated AI antigen per subtype proved to have a high sensitivity and specificity compared to HI test in experimental sera. Two AI antigens were necessary to circumvent interference with the N protein. These ELISAs detected H5 and H7 antibodies earlier during experimental infection compared to the HI test both when performed once and as 2 subsequent ELISAs. Thus the ELISAs may represent an alternative to HI test for screening for AI H5 and H7 antibodies.

Abbreviations

AEC: 

3-amino-9-ethylcarbazole

AGID: 

Agar gel immunodiffusion

AIV: 

Avian influenza virus

APMV: 

Avian paramyxovirus

BSA: 

Bovine serum albumin

CEF: 

Chicken embryofibroblast

EURL: 

EU Reference Laboratory for Avian Influenza, Virology Department, AHVLA Weybridge, United Kingdom

ELISA: 

Enzyme-linked immunosorbent assay

H: 

Haemagglutinin

HA: 

Haemagglutiniation

HI: 

Haemagglutinin inhibition

HPAI: 

Highly pathogenic avian influenza

Inh%: 

Inhibition percentage

IPX: 

Immunochemistry with immunoperoxidase test

mAb: 

Monoclonal antibody

N: 

Neuramindase

NP: 

Nucleoprotein

OP: 

Optical density

PBS: 

Phosphate buffered saline

RBC: 

Red blood cells

Rt: 

Room temperature

ROC: 

Receiver operating characteristic

SPF: 

Absence of avian adenovirus group 1, avian encephalomyelitis virus, avian infectious bronchitis virus, avian infectious laryngotracheitis virus, avian leucosis virus, avian nephritis virus, avian orthoreovirus, avian reticuloendotheliosis virus, chicken anaemia virus, egg drop syndrome virus, infectious bursal disease virus, influenza A virus, Marek’s disease virus, Newcastle disease virus, Turkey rhinotracheitis virus, mycoplasma gallisepticum, mycoplasma synoviae, salmonella pullorum

VET: 

National Veterinary Institute, Technical University of Denmark.

Declarations

Acknowledgements

The technical assistance of Lisbeth Nielsen and Hanne Røigaard-Petersen is highly appreciated. This work was founded by the EU projects AVIFLU and FLUTEST.

Authors’ Affiliations

(1)
Department of Poultry, Fish and Fur Animals, National Veterinary Institute, Technical University of Denmark
(2)
Department of Virology, Animal Health and Veterinary Laboratories Agency, AHVLA
(3)
avian and rabbit virology immunology and parasitology unit, Anses Ploufragan Plouzané Laboratory
(4)
Department of Veterinary Epidemiology, National Veterinary Institute, Technical University of Denmark
(5)
Department of Biotechnology, Chemistry and Environmental Engineering, Faculty of Engineering and Science/Aalborg Zoo

References

  1. Alexander DJ: An overview of the epidemiology of avian influenza. Vaccine. 2007, 25: 5637-5644. 10.1016/j.vaccine.2006.10.051.View ArticlePubMedGoogle Scholar
  2. Banks J, Speidel EC, McCauley JW, Alexander DJ: Phylogenetic analysis of H7 haemagglutinin subtype influenza A viruses. Arch Virol. 2000, 145: 1047-1058. 10.1007/s007050050695.View ArticlePubMedGoogle Scholar
  3. Claas EC, Osterhaus AD, van BR, de Jong JC, Rimmelzwaan GF, Senne DA, Krauss S, Shortridge KF, Webster RG: Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet. 1998, 351: 472-477. 10.1016/S0140-6736(97)11212-0.View ArticlePubMedGoogle Scholar
  4. Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, Munster V, Kuiken T, Rimmelzwaan GF, Schutten M, Van Doornum GJ, Koch G, Bosman A, Koopmans M, Osterhaus AD: Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci USA. 2004, 101: 1356-1361. 10.1073/pnas.0308352100.PubMed CentralView ArticlePubMedGoogle Scholar
  5. Capua I, Alexander D: Perspectives on the global threat: the challenge of avian influenza viruses for the world’s veterinary community. Avian Dis. 2010, 54: 176-178. 10.1637/8870-041009-Reg.1.View ArticlePubMedGoogle Scholar
  6. OIE Manual: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the World Organisation for Animal Health (OIE). Chapers. 2012, 2.3.4: 441-442.Google Scholar
  7. De Boer GF, Back W, Osterhaus AD: An ELISA for detection of antibodies against influenza A nucleoprotein in humans and various animal species. Arch Virol. 1990, 115: 47-61. 10.1007/BF01310622.View ArticlePubMedGoogle Scholar
  8. Moreno A, Brocchi E, Lelli D, Gamba D, Tranquillo M, Cordioli P: Monoclonal antibody based ELISA tests to detect antibodies against neuraminidase subtypes 1, 2 and 3 of avian influenza viruses in avian sera. Vaccine. 2009, 27: 4967-4974. 10.1016/j.vaccine.2009.05.089.View ArticlePubMedGoogle Scholar
  9. Shafer AL, Katz JB, Eernisse KA: Development and validation of a competitive enzyme-linked immunosorbent assay for detection of type A influenza antibodies in avian sera. Avian Dis. 1998, 42: 28-34. 10.2307/1592573.View ArticlePubMedGoogle Scholar
  10. Sullivan HJ, Blitvich BJ, VanDalen K, Bentler KT, Franklin AB, Root JJ: Evaluation of an epitope-blocking enzyme-linked immunosorbent assay for the detection of antibodies to influenza A virus in domestic and wild avian and mammalian species. J Virol Methods. 2009, 161: 141-146. 10.1016/j.jviromet.2009.06.001.View ArticlePubMedGoogle Scholar
  11. Wu R, Hu S, Xiao Y, Li Z, Shi D, Bi D: Development of indirect enzyme-linked immunosorbent assay with nucleoprotein as antigen for detection and quantification of antibodies against avian influenza virus. Vet Res Commun. 2007, 31: 631-641. 10.1007/s11259-007-3510-x.View ArticlePubMedGoogle Scholar
  12. Yang M, Berhane Y, Salo T, Li M, Hole K, Clavijo A: Development and application of monoclonal antibodies against avian influenza virus nucleoprotein. J Virol Methods. 2008, 147: 265-274. 10.1016/j.jviromet.2007.09.016.View ArticlePubMedGoogle Scholar
  13. Zhou EM, Chan M, Heckert RA, Riva J, Cantin MF: Evaluation of a competitive ELISA for detection of antibodies against avian influenza virus nucleoprotein. Avian Dis. 1998, 42: 517-522. 10.2307/1592678.View ArticlePubMedGoogle Scholar
  14. Upadhyay C, Ammayappan A, Vakharia VN: Detection of NP, N3 and N7 antibodies to avian influenza virus by indirect ELISA using yeast-expressed antigens. Virol J. 2009, 6: 158-10.1186/1743-422X-6-158.PubMed CentralView ArticlePubMedGoogle Scholar
  15. Jin M, Wang G, Zhang R, Zhao S, Li H, Tan Y, Chen H: Development of enzyme-linked immunosorbent assay with nucleoprotein as antigen for detection of antibodies to avian influenza virus. Avian Dis. 2004, 48: 870-878. 10.1637/7226-062204r.View ArticlePubMedGoogle Scholar
  16. Brown JD, Stallknecht DE, Berghaus RD, Luttrell MP, Velek K, Kistler W, Costa T, Yabsley MJ, Swayne D: Evaluation of a commercial blocking enzyme-linked immunosorbent assay to detect avian influenza virus antibodies in multiple experimentally infected avian species. Clin Vaccine Immunol. 2009, 16: 824-829. 10.1128/CVI.00084-09.PubMed CentralView ArticlePubMedGoogle Scholar
  17. Marche S, van den BT: Evaluation of different strategies for the use of ELISA tests as first screening tools for serologic surveillance of low pathogenic avian influenza in the Belgian poultry sector. Avian Dis. 2010, 54: 627-631. 10.1637/8759-033109-Reg.1.View ArticlePubMedGoogle Scholar
  18. Perez-Ramirez E, Rodriguez V, Sommer D, Blanco JM, Acevedo P, Heffels-Redmann U, Hofle U: Serologic testing for avian influenza viruses in wild birds: comparison of two commercial competition enzyme-linked immunosorbent assays. Avian Dis. 2010, 54: 729-733. 10.1637/8802-040109-ResNote.1.View ArticlePubMedGoogle Scholar
  19. Spackman E, Pantin-Jackwood MJ, Swayne DE, Suarez DL: An evaluation of avian influenza diagnostic methods with domestic duck specimens. Avian Dis. 2009, 53: 276-280. 10.1637/8520-111708-Reg.1.View ArticlePubMedGoogle Scholar
  20. Shiraishi R, Nishiguchi A, Tsukamoto K, Muramatsu M: Comparison of commercial enzyme-linked immunosorbent assay kits with agar gel precipitation and hemagglutination-inhibition tests for detecting antibodies to avian influenza viruses. J Vet Med Sci. 2012, 74: 1217-1220. 10.1292/jvms.12-0086.View ArticlePubMedGoogle Scholar
  21. Lebarbenchon C, Brown JD, Luttrell MP, Stallknecht DE: Comparison of two commercial enzyme-linked immunosorbent assays for detection of Influenza A virus antibodies. J Vet Diagn Invest. 2012, 24: 161-165. 10.1177/1040638711416626.View ArticlePubMedGoogle Scholar
  22. Yang M, Clavijo A, Graham J, Pasick J, Neufeld J, Berhane Y: Evaluation of diagnostic applications of monoclonal antibodies against avian influenza H7 viruses. Clin Vaccine Immunol. 2010, 17: 1398-1406. 10.1128/CVI.00023-10.PubMed CentralView ArticlePubMedGoogle Scholar
  23. Sala G, Cordioli P, Moreno-Martin A, Tollis M, Brocchi E, Piccirillo A, Lavazza A: ELISA test for the detection of influenza H7 antibodies in avian sera. Avian Dis. 2003, 47: 1057-1059. 10.1637/0005-2086-47.s3.1057.View ArticlePubMedGoogle Scholar
  24. Shien JH, Fu LF, Wu JR, Cheng MC, Shieh HK, Chang PC: Development of blocking ELISA for detection of antibodies against avian influenza virus of the H7 subtype. J Microbiol Immunol Infect. 2008, 41: 369-376.PubMedGoogle Scholar
  25. Dlugolenski D, Hauck R, Hogan RJ, Michel F, Mundt E: Production of H5-specific monoclonal antibodies and the development of a competitive enzyme-linked immunosorbent assay for detection of H5 antibodies in multiple species. Avian Dis. 2010, 54: 644-649. 10.1637/8683-030909-ResNote.1.View ArticlePubMedGoogle Scholar
  26. Chen Y, Xu F, Fan X, Luo H, Ge S, Zheng Q, Xia N, Chen H, Guan Y, Zhang J: Evaluation of a rapid test for detection of H5N1 avian influenza virus. J Virol Methods. 2008, 154: 213-215. 10.1016/j.jviromet.2008.08.013.View ArticlePubMedGoogle Scholar
  27. De Marco MA, Foni E, Campitelli L, Delogu M, Raffini E, Chiapponi C, Barigazzi G, Cordioli P, Di TL, Donatelli I: Influenza virus circulation in wild aquatic birds in Italy during H5N2 and H7N1 poultry epidemic periods (1998 to 2000). Avian Pathol. 2005, 34: 480-485. 10.1080/03079450500368185.View ArticlePubMedGoogle Scholar
  28. Moreno A, Lelli D, Brocchi E, Sozzi E, Vinco LJ, Grilli G, Cordioli P: Monoclonal antibody-based ELISA for detection of antibodies against H5 avian influenza viruses. J Virol Methods. 2013, 187: 424-430. 10.1016/j.jviromet.2012.11.006.View ArticlePubMedGoogle Scholar
  29. Neumann G, Chen H, Gao GF, Shu Y, Kawaoka Y: H5N1 influenza viruses: outbreaks and biological properties. Cell Res. 2009, 20: 51-61.PubMed CentralView ArticlePubMedGoogle Scholar
  30. Bragstad K, Jørgensen PH, Handberg KJ, Mellergaard S, Corbet S, Fomsgaard A: New avian influenza A virus subtype combination H5N7 identified in Danish mallard ducks. Virus Res. 2005, 109: 181-190. 10.1016/j.virusres.2004.12.004.View ArticlePubMedGoogle Scholar
  31. Jørgensen PH, Nielsen OL, Hansen HC, Manvell RJ, Banks J, Alexander DJ: Isolation of influenza a virus, subtype H5N2, and avian paramyxovirus type 1 from a flock of ostriches in Europe. Avian Pathol. 1998, 27: 15-20. 10.1080/03079459808419269.View ArticlePubMedGoogle Scholar
  32. Cherbonnel M, Rousset J, Jestin V: Strategies to improve protection against low-pathogenicity H7 avian influenza virus infection using DNA vaccines. Avian Dis. 2003, 47: 1181-1186. 10.1637/0005-2086-47.s3.1181.View ArticlePubMedGoogle Scholar
  33. Pauli G, Gregersen JP, Ludwig H: Plaque/focus immunoassay: a simple method for detecting antiviral monoclonal or other antibodies and viral antigens in cells. J Immunol Methods. 1984, 74: 337-344. 10.1016/0022-1759(84)90301-6.View ArticlePubMedGoogle Scholar
  34. Comin A, Toft N, Stegeman A, Klinkenberg D, Marangon S: Serological diagnosis of avian influenza in poultry: is the haemagglutination inhibition test really the ‘gold standard’?. Influenza Other Respi Viruses. 2013, 7: 257-264. 10.1111/j.1750-2659.2012.00391.x.View ArticleGoogle Scholar
  35. Chen YC, Chen CH, Wang CH: H5 antibody detection by blocking enzyme-linked immunosorbent assay using a monoclonal antibody. Avian Dis. 2008, 52: 124-129. 10.1637/8076-071807-Reg.View ArticlePubMedGoogle Scholar
  36. Song DS, Lee YJ, Jeong OM, Kim YJ, Park CH, Yoo JE, Jeon WJ, Kwon JH, Ha GW, Kang BK, Lee CS, Kim HK, Jung BY, Kim JH, Oh JS: Evaluation of a competitive ELISA for antibody detection against avian influenza virus. J Vet Sci. 2009, 10: 323-329. 10.4142/jvs.2009.10.4.323.PubMed CentralView ArticlePubMedGoogle Scholar
  37. Starick E, Werner O, Schirrmeier H, Kollner B, Riebe R, Mundt E: Establishment of a competitive ELISA (cELISA) system for the detection of influenza A virus nucleoprotein antibodies and its application to field sera from different species. J Vet Med B Infect Dis Vet Public Health. 2006, 53: 370-375. 10.1111/j.1439-0450.2006.01007.x.View ArticlePubMedGoogle Scholar
  38. Watcharatanyatip K, Boonmoh S, Chaichoun K, Songserm T, Woratanti M, Dharakul T: Multispecies detection of antibodies to influenza A viruses by a double-antigen sandwich ELISA. J Virol Methods. 2010, 163: 238-243. 10.1016/j.jviromet.2009.09.027.View ArticlePubMedGoogle Scholar

Copyright

© Jensen et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement